A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/15744236

Download in:

View as

General Info

PMID
15744236